PMID: 2252321Jan 1, 1990Paper

Serotonergic control of cerebral activity and behavior: models of dementia

Annals of the New York Academy of Sciences
C H VanderwolfC Dickson

Abstract

No abstract listed.

References

Jun 12, 1978·Annals of the New York Academy of Sciences·C KöhlerS O Ogren
Jun 12, 1978·Annals of the New York Academy of Sciences·H G BaumgartenH G Schlossberger
Feb 1, 1978·Journal of Comparative and Physiological Psychology·C H VanderwolfR K Cooley
Jan 1, 1986·British Medical Bulletin·M Rossor, L L Iversen
Jan 1, 1986·British Medical Bulletin·D M Bowen, A N Davison
Jan 1, 1988·International Review of Neurobiology·C H Vanderwolf
Jan 1, 1986·British Medical Bulletin·G W Fenton
Jan 1, 1986·Neuropsychobiology·G M Whitford
Jan 1, 1971·Neuropharmacology·H C Fibiger, B A Campbell
Dec 1, 1973·European Journal of Pharmacology·B V Clineschmidt
Jan 1, 1972·Zeitschrift für Zellforschung und mikroskopische Anatomie·H G Baumgarten, L Lachenmayer
Dec 1, 1984·Brain Research Bulletin·E O'Hearn, M E Molliver
Oct 20, 1980·Life Sciences·S C Gerson, R J Baldessarini
Nov 1, 1984·Electroencephalography and Clinical Neurophysiology·L S Leung
Jan 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·B Mahendra
Jul 1, 1983·Behavioural Brain Research·J J HaganS D Iversen
Jun 1, 1980·Pharmacology, Biochemistry, and Behavior·S E File, J F Deakin
Nov 1, 1949·Electroencephalography and Clinical Neurophysiology·G Moruzzi, H W Magoun
Jan 30, 1985·Virology·C K ShewmakerR C Gardner

❮ Previous
Next ❯

Citations

Mar 1, 1992·Electroencephalography and Clinical Neurophysiology·C H Vanderwolf
Apr 1, 1990·Pharmacology, Biochemistry, and Behavior·C H VanderwolfG B Baker
Nov 1, 1994·Pharmacology, Biochemistry, and Behavior·H C DringenbergC H Vanderwolf
Sep 1, 1993·Behavioral and Neural Biology·J H McLeanS R King
Aug 1, 1994·Brain Research. Brain Research Reviews·C H Vanderwolf, D P Cain
Jul 1, 1994·Progress in Neurobiology·J SirviöP J Riekkinen
Jan 1, 1994·Brain Research Bulletin·H C Dringenberg, C H Vanderwolf
Dec 18, 2001·Brain Research·G BucktonC H Vanderwolf
Mar 1, 2000·Brain Research·C H Vanderwolf
May 14, 1998·Neuroscience and Biobehavioral Reviews·C H Vanderwolf
May 14, 1998·Neuroscience and Biobehavioral Reviews·H C Dringenberg, C H Vanderwolf
Jan 6, 2000·Progress in Neurobiology·C M PortasR Ursin
Dec 31, 1992·Behavioural Brain Research·C H Vanderwolf
Sep 26, 2006·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·J L W BosboomE Ch Wolters
May 11, 1992·Annals of the New York Academy of Sciences·G A Ricaurte, U D McCann
Jan 1, 1998·Nutritional Neuroscience·E Olvera-CortésA Feria-Velasco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.